Literature DB >> 11501498

Prevalence of Chlamydia pneumoniae in acute respiratory tract infection and detection of anti-Chlamydia pneumoniae-specific IgE in Japanese children with reactive airway disease.

S Ikezawa1.   

Abstract

We examined the prevalence of Chlamydia pneumoniae in acute respiratory tract infection and association of C. pneumoniae infection and reactive airway disease in Japanese children. Four hundred eleven children with acute respiratory tract infection were enrolled in this study, and C. pneumoniae was isolated from 58 (14.1%) patients by culture. Evidence of infection with C. pneumoniae was detected in 58 children with pneumonia (34.5%), bronchitis (41.4%) and upper respiratory tract infection (24.1%). Twenty-nine (50.0%) out of 58 patients were younger than 5 years old and 18 (31.0%) had wheezing at first visit. A logistic test for anti-C. pneumoniae-specific IgE showed the deference in the fluorescence unit between the patients with C. pneumoniae infection with and without wheezing was statistically significant (Po = 0.02748, to = 2.31891). In conclusion, C. pneumoniae seems to be an important respiratory tract pathogen among young Japanese children, and our results support the association of C. pneumoniae infection and reactive airway disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501498     DOI: 10.2739/kurumemedj.48.165

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  3 in total

1.  Chlamydia pneumoniae-Induced IFN-Gamma Responses in Peripheral Blood Mononuclear Cells Increase Numbers of CD4+ but Not CD8+ T Effector Memory Cells.

Authors:  Tamar A Smith-Norowitz; Sarah Shidid; Yitzchok M Norowitz; Stephan Kohlhoff
Journal:  J Blood Med       Date:  2021-05-31

2.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

3.  Azithromycin decreases Chlamydia pneumoniae-mediated Interleukin-4 responses but not Immunoglobulin E responses.

Authors:  Tamar A Smith-Norowitz; Yvonne Huang; Jeffrey Loeffler; Elliot Klein; Yitzchok M Norowitz; Margaret R Hammerschlag; Rauno Joks; Stephan Kohlhoff
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.